Awarded contract

Design and execution of research and development

Details

Buyer: Ulster University
Supplier(s): Fusion Antibodies plc
Value: GBP 232,575
Topic: Design and execution of research and development
Published: 19 November 2020
Source: TedNotices

Tender description

Development of a novel therapeutic antibody for Covid-19. This project is part of a rapid Covid SFI response call where there is an urgency to develop new therapies and solutions to tackle the current Covid-19 pandemic. Development of a novel therapeutic antibody for Covid-19. This project is part of a rapid Covid SFI response call where there is an urgency to develop new therapies and solutions to tackle the current Covid-19 pandemic. A research agreement has been developed between UU, Fusion Antibodies, Queens University Belfast and Trinity College Dublin in the delivery of this Covid project. The proposed drug therapy is the first of its kind. It is a novel dual biological antibody therapy which will act as an anti-viral and anti-inflammatory agent.

Timeline

Completed: Award date1 November 2020
Completed: Award published19 November 2020
Current notice

About the buyer

Ulster University is a public sector buyer in United Kingdom publishing tenders and awards on Stotles. Explore their procurement activity and find more opportunities like this one.

Relevant CPV codes

73300000 · Design and execution of research and development

Decision makers

Connect with the people behind this procurement.

Job title	Phone number	Work email
Head of Procurement	+44 •••• ••••••	••••••••@ulster-university.gov
Commercial Director	+44 •••• ••••••	••••••••@ulster-university.gov
Procurement Manager	+44 •••• ••••••	••••••••@ulster-university.gov
Category Lead	+44 •••• ••••••	••••••••@ulster-university.gov
Senior Buyer	+44 •••• ••••••	••••••••@ulster-university.gov
Contracts Manager	+44 •••• ••••••	••••••••@ulster-university.gov